 |
 |
|
 |
||
Print 
Download Reader 
|
|
|
|
||
Print Download Reader
 |
|
|
National Vaccine Program OfficeNational Vaccine Advisory Committee
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Tuesday, February 3 |
||
9:00 |
Opening Session |
Dr. Peter |
9:15 |
Report from the NVPO |
|
9:25 |
Welcome from the Acting Assistant Secretary for Health |
Dr. Beato |
Influenza 2003-2004: Review and Lessons Learned for Next Year and the Future |
||
9:30 |
The Current Season: Virus/Disease/Vaccine & Efficacy |
|
9:50 |
Vaccine strain selection process and regulatory issues |
Dr. Weir |
10:10 |
Public Perception of Influenza/Influenza Vaccine |
Dr. Nowak |
10:30 |
Discussion |
Dr. Peter |
10:45 |
Break |
|
Perspectives of Influenza Vaccine Manufacturers |
||
11:00 |
AventisPasteur |
|
11:15 |
Chiron |
Dr. Lewin |
11:30 |
MedImmune/Wyeth |
|
11:45 |
Baxter |
Dr. Fusco |
12:00 |
Discussion and Public Comment |
Dr. Peter |
12:30 |
Lunch |
|
Influenza—continued |
||
1:30 |
Public sector roles in adult and childhood influenza vaccination |
|
1:45 |
CMS: Financing and Quality Improvement Organizations Efforts |
|
2:00 |
Perspective of Health Plans and Insurers |
Mr. Rehm |
2:15 |
Influenza Vaccine R&D Toward a “Better” Vaccine |
|
2:30 |
Pandemic Influenza Preparedness |
|
2:45 |
Discussion and Public Comment |
|
3:00 |
Next Steps |
Dr. Peter |
3:30 |
Subcommittee Meetings |
|
|
||
Wednesday, February 4 |
||
Working Group Updates and Reports |
||
8:30 |
Polio Laboratory Containment, Phase 1: FINAL REPORT |
Dr. Arvin/Dr. Dowdle |
9:00 |
Polio Vaccine Stockpile |
Dr. Helms/Dr. Alexander |
9:30 |
Public Participation in Vaccine Decision Making |
Ms. Katz |
9:45 |
Public Health Options for Implementing Vaccine Recommendations |
Dr. Williamson/Dr Santoli |
10:45 |
Break |
|
11:00 |
Vaccine Financing |
Dr. Hinman/Dr. Smith |
11:15 |
DMSS Working Group on Anthrax Vaccine Safety |
Dr. Davis/Dr. McNeil |
Subcommittee Updates and Reports |
||
11:30 |
Immunization Coverage Subcommittee |
Dr. Whitley-Williams |
11:45 |
Future Vaccines Subcommittee |
Dr. Fast |
12:00 |
Vaccine Safety and Communication Subcommittee |
Dr. Klein |
12:15 |
Lunch |
|
1:00 |
Vaccine Management Business Improvement Project |
Ms. Lane |
1:15 |
Project BioShield |
|
Thimerosal/Autism Litigation |
||
1:30 |
Vaccine Injury Compensation Program |
Ms. Saindon |
1:50 |
Civil Litigation - Update |
Mr. Moss |
2:10 |
Discussion |
|
HHS Agencies/Committees Reports |
||
2:20 |
ACCV/DVIC Report |
Ms. Noyes/Dr. Evans |
2:30 |
VRPBAC/FDA Report |
Dr. Overturf/Dr. Baylor |
2:40 |
ACIP/NIP Report |
|
2:50 |
NIH |
Dr. Curlin |
3:00 |
Public Comment |
|
3:15 |
Adjourn |
|
Last Updated: March 30, 2004
|
